Hostname: page-component-745bb68f8f-b6zl4 Total loading time: 0 Render date: 2025-02-06T00:45:40.429Z Has data issue: false hasContentIssue false
  • English
  • Français

The role of intraovarian regulators in the aetiology of polycystic ovarian syndrome

Published online by Cambridge University Press:  03 June 2009

Ghanim Almahbobi  and
Alan O Trounson
Ghanim Almahbobi*
Affiliation:
Human and Animal Reproductive Biology Group, Institute of Reproduction and Development, Monash University, Clayton, Vic, Australia
Alan O Trounson
Affiliation:
Human and Animal Reproductive Biology Group, Institute of Reproduction and Development, Monash University, Clayton, Vic, Australia
*
Institute of Reproduction and Development, Level 3, Block E, Monash Medical Centre, 246 Clayton Road, Clayton, Vic., 3168, Australia.
Get access Rights & Permissions [Opens in a new window]

Extract

The present review demonstrates that the availability of bioactive FSH and LH in PCOS is normal and that granulosa cells of PCO are not apoptotic and instead hyperexpress functional FSH receptors and may possess intact aromatase activity. Consequently, these cells respond excessively to exogenous FSH stimulation and produce high amounts of oestradiol both in vivo and in vitro. The altered developmental capacity of follicles from PCO in vivo is most likely due to the abnormal follicular milieu of PCO and the culminating effects of intrafollicular inhibitors and stimulators. The failure of ovarian oestradiol production and follicular maturation to dominance in vivo may be due to a mechanism that interferes with the function of FSH, such as intraovarian steroids and growth factors. It has previously been shown that EGF and TGFα have inhibitory actions on follicular development, aromatization and LH receptor formation. In contrast, EGF enhances early follicular recruitment and growth. Therefore, it is hypothesized that EGF/TGFα may have a causal relationship in the mechanisms of anovulatory infertility in women with PCOS. Thus, an aberration in the regulation of follicular fluid EGF and/or TGFα may result in reduced numbers of granulosa cells, cessation of follicle selection and ultimately in the creation and maintenance of PCOS. The exact mechanism by which the hyperfunction of EGF/TGFα occurs and the trigger for this hyperactivity in the ovary remain to be determined. An experimental animal model may be required to assist such investigations in the future.

Type
Research Article
Information
Reproductive Medicine Review , Volume 5 , Issue 3 , October 1996 , pp. 151 - 168
Copyright
Copyright © Cambridge University Press 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Stein, IF, Leventhal, ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181–91.Google Scholar
2Culiner, A, Shippel, S. Virilism and theca cell hyperplasia of the polycystic ovary syndrome. J Obstet Gynaecol Br Commonw 1949; 56: 435–39.CrossRefGoogle Scholar
3Goldzieher, JW, Green, JA. The polycystic ovary. I. Clinical and histologic features. J Clin Endocrinol Metab 1962; 22: 325–38.Google Scholar
4Mason, HD, Willis, DS, Beard, RW, Winston, RML, Margara, R, Franks, S. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. J Clin Endocrinol Metab 1994; 79: 1355–60.Google Scholar
5Adams, J, Polson, DW, Franks, S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ 1986; 293: 355–59.CrossRefGoogle ScholarPubMed
6Ehrmann, DA, Barnes, RB, Rosenfield, RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocrinol Reviews 1995; 16: 322–53.Google Scholar
7Franks, S, Mason, HD, Poison, DW, Winston, RML, Margara, R, Reed, MJ. Mechanism and management of ovulatory failure in women with polycystic ovary syndrome. Hum Reprod 1988; 3: 531–34.Google Scholar
8Armar, NA, McGarrigle, HHG, Honour, J, Holownia, P, Jacobs, HS, Lachelin, GCL. Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: Endocrinole changes and clinical outcome. Fertil Steril 1990; 53: 45–49.Google Scholar
9Rajaniemi, HJ, Ronnberg, L, Kauppila, A, Ylostalo, P, Vihko, R. Luteinizing hormone receptors in ovarian follicles of patients with polycystic ovarian disease. J Clin Endocrinol Metab 1980; 51: 1054–57.Google Scholar
10Haney, AF, Maxson, WS, Schomberg, DW. Compartmental ovarian steroidogenesis in polycystic ovary syndrome. Obstet Gynecol 1986; 68: 638–44.Google Scholar
11Yen, SSC. The polycystic ovary syndrome. Clin Endocrinol 1980; 12: 177–208.Google Scholar
12Gilling-Smith, C, Franks, S. Polycystic ovary syndrome. Reprod Med Rev 1993; 2: 15–32.Google Scholar
13Franks, S. Morphology of the polycystic ovary. In: Dunaif, A, Givens, J, Haseltime, F, Merriam, G eds. Current issues in endocrinolology and metabolism: polycystic ovary syndrome. Cambridge, MA: Blackwell Scientific, 1992: 19–28.Google Scholar
14Hughesdon, PE. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called ‘hyperthecosis’. Obstet Gynecol Survey 1982; 37: 59–77.CrossRefGoogle ScholarPubMed
15Goldzieher, JW. Polycystic ovarian disease. Fertil Steril 1981; 35: 371–94.Google ScholarPubMed
16Erickson, GF. Folliculogenesis in polycystic ovary syndrome. In: Dunaif, A, Givens, J, Haseltime, F, Merriam, G eds. Current issues in endocrinolology and metabolism: polycystic ovary syndrome. Cambridge, MA: Blackwell Scientific, 1992: 111–28.Google Scholar
17Green, JA, Goldzieher, JW. The polycystic ovary. IV. Light and electron microscopy studies. Am J Obstet Gynecol 1965; 91: 173–81.Google Scholar
18Leventhal, ML. Functional and morphologic studies of the ovaries and suprarenal glands in the Stein-Leventhal syndrome. Am J Obstet Gynecol 1962; 84: 154–64.Google Scholar
19Almahbobi, G, Silberzahn, N, Fakhri, R, Silberzahn, P. Steroidogenic characteristics of the adrenal cortex of the mare studied by electron microscopy. Arch Anat Micr Morphol Exp 1985; 74: 193–203.Google ScholarPubMed
20Almahbobi, G. Evolution morphologique et fonctionnelle des tissus steroidogenes des gonades equines. PhD Thesis, University of Caen, France, 1987.Google Scholar
21Almahbobi, G, Papadopoulos, V, Carreau, S, Silberzahn, P. Age-related morphological and functional changes in the leydig cells of the horse. Biol Reprod 1988; 38: 653–65.CrossRefGoogle ScholarPubMed
22Silberzahn, P, Almahbobi, G, Dehennin, L, Merouane, A. Estrogen metabolites in equine ovarian follicles: gas chromatographic-mass spectrometric determinations in relation to follicular ultrastructure and progestin content. J Steroid Biochem 1985; 22: 501–505.Google Scholar
23Rebar, R, Judd, HL, Yen, SSC, Rakoff, J, Van Den Berg, G, Naftolin, F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 1976: 57: 1320–29.Google Scholar
24Short, RV. Further observations on the defective sybthesis of ovarian steroids in the Stein-Leventhal syndrome. J Endocrinol 1962; 24: 359.Google Scholar
25McNatty, KP, Smith, P, Hudson, NL, Heath, DA, Lun, S, Ws, O. Follicular development and steroidogenesis. In: Local regulation of ovarian function. The Parthenon Publishing Group, 1992: 21–38.Google Scholar
26Hull, MGR. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1987; 1: 235–45.Google Scholar
27Takahashi, K, Eda, Y, Okada, S, Abu-Musa, A, Yoshino, K, Kitao, M. Morphological assessment of polycystic ovary using transvaginal ultrasound. Hum Reprod 1993; 8: 844–49.Google Scholar
28Trounson, A, Wood, C, Kausche, A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril 1994; 62: 353–62.Google Scholar
29Polson, DW, Adams, J, Wadsworth, J, Franks, S. Polycystic ovaries – a common finding in normal women. Lancet 1988; i: 870–72.Google Scholar
30Clayton, RN, Ogden, V, Hodgkinson, J et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol 1992; 37: 127–34.Google Scholar
31Franks, S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol 1989; 31: 87–120.Google Scholar
32Norman, RJ, Hague, WM, Masters, SC, Wang, XJ. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod 1995; 10: 2258–61.Google Scholar
33Almahbobi, G, Anderiesz, C, Hutchinson, P, McFarlane, JR, Wood, C, Trounson, AO. Functional integrity of granulosa cells from polycystic ovaries. Clin Endocrinol 1996; 44: 571–80.Google Scholar
34Franks, S, Hamilton-Fairley, D, Kiddy, DS, Mason, HD. Growth factors and the polycystic ovary. In: Local regulation of ovarian function. The Parthenon Publishing Group, 1992: 97–106.Google Scholar
35Suikkari, A-M, MacLachlan, V, Montalto, J, Calderon, I, Healy, DL, McLachlan, RI. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment. Hum Reprod 1995; 10: 513–19.Google Scholar
36Mahajan, DK. Steroidogenesis in human polycystic ovary. Endocrinol Metab Clin North Am 1988; 17: 751–68.Google Scholar
37Rosenfield, RL, Barnes, RB, Cara, J'F, Lucky, AW. Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome. Fertil Steril 1990; 53: 785–92.Google Scholar
38Erickson, GF, Magoffin, DA, Garzo, VG, Cheung, AP, Chang, RJ. Granulosa cells of polycystic ovaries: are they normal or abnormal. Hum Reprod 1992; 7: 293–99.CrossRefGoogle ScholarPubMed
39MacDougall, MJ, Tan, SL, Balen, A, Jacobs, HS. A controlled study comparing patients with and without polycystic ovaries undergoing in vitro fertilization. Hum Reprod 1993; 8: 233–37.Google Scholar
40Findlay, JK. An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 1993; 48: 15–23.Google Scholar
41Eden, JA, Jones, J, Carter, GD, Alaghband-Zadeh, J. Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex-steroids in volume matched normal and polycystic human follicles. Clin Endocrinol 1990; 32: 395–405.Google Scholar
42San Roman, GA, Magoffin, DA. Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid. J Clin Endocrinol Metab 1992; 75: 1010–16.Google Scholar
43Short, RV, London, DR. Defective biosynthesis of ovarian steroids in the Stein-Leventhal syndrome. BMJ 1961; i: 1724.Google Scholar
44Axelrod, RL, Goldzieher, JW. Enzymatic inadequacies of human polycystic ovaries. Arch Biochem Biophys 1961; 95: 547.Google Scholar
45Westergaard, LG, Andersen, CY. Epidermal growth factor (EGF) in human preovulatory follicles. Hum Reprod 1989; 4: 257–260.Google Scholar
46Westergaard, LG, Andersen, CY, Byskov, AG. Epidermal growth factor in small antral ovarian follicles of pregnant women. J Endocrinol 1990; 127: 363–67.CrossRefGoogle ScholarPubMed
47Mason, HD, Carr, L, Leake, R, Franks, S. Production of transforming growth factor-α by normal and polycystic ovaries. J Clin Endocrinol Metab 1995; 80: 2053–56.Google Scholar
48Volpe, A, Coukos, G, D'Ambrogio, G, Artini, PG, Genazzani, AR. Follicular fluid steroid and epidermal growth factor content, and in vitro estrogen release by granulosa-luteal cells from patients with polycystic ovaries in an IVF/ET program. Eur J Obstet Gynecol Reprod Biol 1991; 42: 195–99.Google Scholar
49Magoffin, DA, San Roman, GA, Muderspach, LI. Insulin-like growth factor binding proteins in a natural pre-ovulatory follicle from a woman with polycystic ovary syndrome. Hum Reprod 1995; 10: 2248–52.CrossRefGoogle Scholar
50Mason, HD, Margara, R, Winston, RML, Seppala, M, Koistinen, R, Franks, S. Insulin-like growth factor-I (IGF-I) inhibits production of IGF-binding protein-1 while stimulating estradiol secretion in granulosa cells from normal and polycystic human ovaries. J Clin Endocrinol Metab 1993; 76: 1275–79.Google Scholar
51Balen, AH, Tan, S-L, Jacobs, HS. Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage. Br J Obstet Gynaecol 1993; 100: 1082–89.Google Scholar
52Shoham, Z, Jacobs, HS, Insler, V. Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril 1993; 59: 1153–61.Google Scholar
53Homburg, R, Armar, NA, Eshel, A, Adams, J, Jacobs, HS. Influence of serum luteinising hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. BMJ 1988; 297: 1024–26.CrossRefGoogle ScholarPubMed
54Stanger, JD, Yovich, JL. Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinising hormone levels during the follicular phase. Br J Obstet Gynaecol 1985; 92: 385–93.Google Scholar
55Howles, CM, Macnamee, MC, Edwards, RG. Follicular development and early luteal function of conception and non-conception cycles after human in-vitro fertilizaton: endocrine correlates. Hum Reprod 1987; 2: 17–21.Google Scholar
56Punnonen, R, Ashorn, R, Vilja, P, Heinonen, PK, Kujansuu, E, Tuohimas, P. Spontaneous luteinizing hormone surge and cleavage of in vitro fertilized embryos. Fertil Steril 1988; 49: 479–82.CrossRefGoogle ScholarPubMed
57Anderiesz, C, Trounson, AO. The effect of testosterone on the maturation and developmental capacity of murine oocyte. in vitro. Hum Reprod 1995; 10: 2377–81.Google Scholar
58Kumar, J, Osborn, JC, Cameron, AWN, Batt, P, Trounson, AO. Premature condensation of chromatin induced in goat (Capra hircus) oocytes after gonadotrophin treatment. Reprod Fertil Dev 1992; 6: 661–70.Google Scholar
59Trounson, AO, Bongso, A, Szell, A, Barnes, FL. Maturation of human and bovine primary oocytes in vitro for fertilization and embryo transfer. Singapore J Obstet Gynaecol 1996; 27: 78–84.Google Scholar
60Campo, S, Felli, A, Lamanna, MA, Barini, A, Garcea, N. Endocrinole changes and clinical outcome after laparoscopic ovarian resection in women with polycystic ovaries. Hum Reprod 1993; 8: 359–63.Google Scholar
61Goldzieher, JW, Axelrod, LR. Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 1963; 14: 631–53.Google Scholar
62Mahesh, VB, Greenblatt, RB. Steroid secretions of the normal and polycystic ovary. Recent Prog Horm Res 1964; 20: 341–94.Google Scholar
63Axelrod, LR, Goldzieher, JW. The polycystic ovary. V. Alternate pathways of steroid aromatizaron in normal, pregnancy and polycystic ovaries. J Clin Endocrinol Metab 1965; 25: 1275–78.Google Scholar
64Spaeth, DG, Osawa, Y. Estrogen biosynthesis. III. Stereospecificity of aromatization by normal and diseased human ovaries. J Clin Endocrinol Metab 1974; 38: 783–86.Google Scholar
65Mahajan, DK, Shah, PN. Steroidogenesis in the Stein-Leventhal type of polycystic ovarian tissue. Indian J Pathol Microbiol 1968; 11: 33.Google Scholar
66Erickson, GF, Hsueh, AJW, Quigley, ME, Rebar, RW, Yen, SSC. Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J Clin Endocrinol Metab 1979; 49: 514–19.CrossRefGoogle ScholarPubMed
67Wilson, EA, Erickson, GF, Zarutski, P, Finn, AE, Tulchinsky, D, Ryan, KJ. Endocrinole studies of normal and polycystic ovarian tissue. in vitro. Am J Obstet Gynecol 1979; 134: 56–63.Google Scholar
68Mason, HD, Margara, R, Winston, RML, Beard, RW, Reed, MJ, Franks, S. Inhibition of oestradiol production by epidermal growth factor in human granulosa cells of normal and polycystic ovaries. Clin Endocrinol 1990; 33: 511–17.Google Scholar
69Franks, S, Mason, HD. Polycystic ovary syndrome: interaction of follicle stimulating hormone and polypeptide growth factors in oestradiol production by human granulosa cells. J Steroid Biochem Mol Biol 1991; 40: 405–409.Google Scholar
70Erickson, GF, Magoffin, DA, Cragun, JR, Chang, RJ. The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries. J Clin Endocrinol Metab 1990; 70: 894–902.Google Scholar
71Tilly, JL, Kowalski, KI, Johnson, AL, Hsueh, AJW. Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology 1991; 129: 2799–801.Google Scholar
72Tsang, BK, Moon, VS, Simpson, CW et al. Androgen biosynthesis in human ovarian follicles: cellular source, gonadotropic control and adenosine 3′,5′-cyclic monophosphate mediation. J Clin Endocrinol Metab 1979; 48: 153.Google Scholar
73Gilling-Smith, C, Willis, DS, Beard, RW, Franks, S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 1994; 79: 1158–65.Google Scholar
74Hsueh, AJW, Welsh, TH, Jones, PBC. Inhibition of ovarian and testicular steroidogenesis by epidermal growth factor. Endocrinology 1981; 108: 2002–2004.Google Scholar
75Steinkampf, MP, Mendelson, CR, Simpson, ER. Effects of epidermal growth factor and insulin-like growth factor I on the levels of mRNA encoding aromatase cytochrome P-450 of human ovarian granulosa cells. Mol Cell Endocrinol 1988; 59: 93–99.Google Scholar
76Maruo, T, Ladines-Llave, CA, Samoto, T et al. Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression. Endocrinology 1993; 132: 924–31.Google Scholar
77Barnes, FL, Kausche, A, Tiglias, J, Wood, C, Wilton, L, Trounson, A. Production of embryos from in vitro matured primary human oocytes. Fertil Steril 1996; 65: 1151–56.Google Scholar
78Barnes, FL, Crombie, A, Gardner, DK, Kausche, A, Lacham-Kaplan, O, Suikkari, A-M, Tiglias, J, Wood, C, Trounson, AO. Blastocyst development and birth after in vitro maturation of human primary oocytes, intracytoplasmic sperm injection and assisted hatching. Hum Reprod 1995; 10: 101–105.Google Scholar
79Byskov, AG. Atresia. In: Migley, AR, Sadler, WA eds. Ovarian follicular development and function. NY: Raven Press, 1979: 41–58.Google Scholar
80Takahashi, K, Eda, Y, Abu-Musa, A, Okada, S, Yoshino, K, Kitao, M. Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome. Hum Reprod 1994; 9: 1231–36.Google Scholar
81McNatty, KP, Moore, Smith D, Makris, A, Osathanondh, R, Ryan, KJ. The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo an. in vitro. J Clin Endocrinol Metab 1979; 49: 851–60.Google Scholar
82Axelrod, LR, Goldzieher, JW. The polycystic ovary VIII. The metabolism of 5-pregnenolone, progesterone, testosterone, Δ-androstenedione, estone by normal and polycystic ovarian tissue. Acta Endocrinol 1967; 56: 255.Google Scholar
83Tamura, T, Kitawaki, J, Yamamoto, T et al. Immunohistochemical localization of 17α-hydroxylase/C17–20 lyase and aromatase cytochrome P-450 in the human ovary during the menstrual cycle. J Endocrinol 1992; 135: 589–95.Google Scholar
84Sasano, H, Okamoto, M, Mason, JI et al. Immunolocalization of aromatase, 17α-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. J Reprod Fertil 1989; 85: 163–69.Google Scholar
85Inkster, SE, Brodie, AMH. Expression of aromatase cytochrome P-450 in premenopausal and postmenopausal human ovaries: an immunocytochemical study. J Clin Endocrinol Metab 1991; 73: 717–26.Google Scholar
86Erickson, GF, Yen, SSC. New data on follicle cells in polycystic ovaries: a proposed mechanism for the genesis of cystic follicles. Semin Reprod Endocrinol 1984; 2: 231–43.Google Scholar
87Vigersky, RA, Loriaux, DL. An androgen-binding protein in the cyst fluid of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 1976; 43: 817–23.Google Scholar
88Burghardt, RC, Anderson, E. Hormonal modulation of gap junctions in rat ovarian follicles. Cell Tissue Res 1981; 214: 181–93.Google Scholar
89Merk, FB, Botticelli, CR, Albright, JT. An intercellular response to estrogen by granulosa cells in the rat ovary: an electron microscope study. Endocrinolology 1972; 90: 992–1007.Google Scholar
90Hillier, SG, Yong, EL, Illingworth, PJ, Baird, DT, Schwall, RH, Mason, AJ. Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol Cell Endocrinol 1991; 75: R1–R6.Google Scholar
91Nestler, JE, Clore, JN, Blackard, WG. The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome. Am J Obstet Gynecol 1989; 161: 1095–97.Google Scholar
92Hall, JE, Taylor, AE, Martin, KA, Crowley, WF Jr. The polycystic ovarian syndrome: new approaches. In: Dunaif, A, Givens, J, Haseltime, F, Merriam, G eds. Current issues in endocrinolology and metabolism: polycystic ovary syndrome. Cambridge, MA: Blackwell Scientific, 1992; 39–49.Google Scholar
93Almahbobi, G, Nagodavithane, A, Trounson, AO. Effects of epidermal growth factor, transforming growth factor (and androstenedione on follicular growth and aromatizaton in culture. Hum Reprod 1995; 10: 2767–72.Google Scholar
94Barnes, RB, Rosenfield, RL, Burstein, S, Ehrmann, DA. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 1989; 320: 559–65.Google Scholar
95Franks, S. The aetiology of polycystic ovary syndrome. Singopore J Obstet Gynaecol 1996; 27: 32–35.Google Scholar
96Derynck, R. Transforming growth factor-α. Cell 1988; 54: 593–95.Google Scholar
97Bendell, JJ, Dorrington, JH. Epidermal growth factor influences growth and differentiation of rat granulosa cells. Endocrinology 1990; 127: 533–40.Google Scholar
98Feng, P, Knecht, M, Catt, K. Hormonal control of epidermal growth factor receptors by gonadotropins during granulosa cell differentiation. Endocrinology 1987; 120: 1121–26.Google Scholar
99Gospodarowicz, D, Bialecki, H. Fibroblast and epidermal growth factors are mitogenic agents for cultured granulosa cells of rodent, porcine, and human origin. Endocrinology 1979; 104: 757–64.Google Scholar
100Murray, JF, Downing, JA, Evans, G, Findlay, JK, Scaramuzzi, RJ. Epidermal growth factor acts directly on the sheep ovary in vivo to inhibit oestradiol-17β and inhibin secretion and enhance progesterone secretion. J Endocrinol 1993; 137: 253–64.CrossRefGoogle ScholarPubMed
101Murray, JF, Downing, JA, Evans, G, Findlay, JK, Scaramuzzi, RJ. Changes in progesterone secretion following treatment with transforming growth factor α (TGF-α) during the follicular phase of the sheep oestrous cycle. J Reprod Fertil 1994; 100: 1–7.Google Scholar
102Knecht, M, Catt, KJ. Modulation of cAMP-mediated differentiation in ovarian granulosa cells by epidermal growth factor and platelet-derived growth factor. J Biol Chem 1983; 258: 2789–94.Google Scholar
103Mondschein, JS, Schomberg, DW. Growth factors modulate gonadotropin receptor induction in granulosa cell cultures. Science 1981; 211: 1179–80.Google Scholar
104Kudlow, JE, Kobrin, MS, Purchio, AF et al. Ovarian transforming growth factor-α gene expression: immunohistochemical localization to the theca-interstitial cells. Endocrinology 1987; 121: 1577–79.Google Scholar
105Rall, LB, Scott, J, Bell, GI. Mouse preproepidermal growth factor synthesis by the kidney and other tissues. Nature 1985; 313: 228–31.CrossRefGoogle ScholarPubMed
106Skinner, MK. Transforming growth factor production and action in the ovarian follicle: theca cell-granulosa cell interactions. In: Hirshfield, AN ed. Growth factors and the ovary. New York, NY: Plenum Press, 1989: 141–50.Google Scholar
107Williams, RS, Schultz, GS, Georghegan, TE, Steffen, MC, Yussman, MA. Variation in the levels of transforming growth factor alpha mRNA during the human menstrual cycle. In: Hirshfield, AN ed. Growth factors and the ovary. New York, NY: Plenum Press, 1988: 205–208.Google Scholar
108Chegini, N, Williams, RS. Immunocytochemical localization of transforming growth factors (TGFs) TGF-α and TGF-β in human ovarian tissues. J Clin Endocrinol Metab 1992; 74: 973–80.Google Scholar
109Almahbobi, G, Hutchinson, P, Misajon, A, Lolatgis, N, Trounson, AO. Localisation and quantitation of epidermal growth factor receptors in granulosa cells of normal and polycystic ovaries. [Abstract no. 45]. Scientific Conference of Endocrine Society of Australia 29 September – 2 10 1996, Manley, NSW, Australia.Google Scholar
110Ma, YJ, Dissen, GA, Merlino, G, Coquelin, A, Ojeda, SR. Overexpression of human transforming growth factor α transgene reveals a dual antagonistic role of TGFα in female sexual development. Endocrinology 1994; 135: 1392–400.CrossRefGoogle ScholarPubMed
111Byyny, RL, Orth, DN, Cohen, S, Doyne, ES. Epidermal growth factor: effects of androgens and adrenergic agents. Endocrinology 1974; 95: 776–82.Google Scholar